Experiment 568656

Worktypes

PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

DEXTRAN SULFATE

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTIBACTERIAL ACTIVITY
OrganismEmpty organism
CitationLARM,O: WADSTROEM,T:. (1994). POLYSACCHARIDES FOR THE TREATMENT OF INFECTIONS CAUSED BY HELICOBACTER PYLORI.. ()
Amount utilized
Compound isolated
DiseaseA COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF INFECTIONS CAUSED BY OR ASSOCIATED WITH HELICOBACTER PYLORI, COMPRISES AS AN ACTIVE CONSTITUENT AN IMMOBILIZED, NEG. CHARGED POLYSACCHARIDE SELECTED FROM THE GROUP CONSISTING OF HEPARIN, HEPARIN SULFATE AND DEXTRAN SULFATE. ALSO DISCLOSED ARE A METHOD FOR DIAGNOSIS OF THE PRESENCE OF H.PYLORI IN A SPECIMEN, A VACCINE, AND A METHOD FOR MANUFG. THE ACTIVE COMPONENT.
Number1
Qualitative resultACTIVE
AnimalAGAR PLATE
Dose expressionCONC USED